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Purpose: The severity of a stroke cannot be described by widely used prehospital 
stroke scales. We investigated the usefulness of the Kurashiki Prehospital Stroke 
Scale (KPSS) for assessing the severity of stroke, compared to the National Insti-
tutes of Health Stroke Scale (NIHSS), in candidate patients for intravenous or intra-
arterial thrombolysis who arrived at the hospital within 6 hours of symptom onset. 
Materials and Methods: We retrospectively analyzed a prospective registry data-
base of consecutive patients included in the Emergency Stroke Therapy program. In 
the emergency department, the KPSS was assessed by emergency medical techni-
cians. A cutoff KPSS score was estimated for candidates of thrombolysis by com-
paring KPSS and NIHSS scores, as well as for patients who actually received 
thrombolytic therapy. Clinical outcomes were compared between patients around 
the estimated cut-off. The independent predictors of outcomes were determined us-
ing multivariate logistic regression analysis. Results: Excellent correlations were 
demonstrated between KPSS and NIHSS within 6 hours (R=0.869) and 3 hours 
(R=0.879) of hospital admission. The optimal threshold value was a score of 3 on 
the KPSS in patients within 3 hours and 6 hours by Youden’s methods. Significant 
associations with a KPSS score ≥3 were revealed for actual intravenous administra-
tion of tissue plasminogen activator (IV-tPA) usage [odds ratio (OR) 125.598; 95% 
confidence interval (CI) 16.443-959.368, p<0.0001] and actual IV-tPA or intra-arte-
rial urokinase (IA-UK) usage (OR 58.733; 95% CI 17.272-199.721, p<0.0001). 
Conclusion: The KPSS is an effective prehospital stroke scale for identifying can-
didates for IV-tPA and IA-UK, as indicated by excellent correlation with the NI-
HSS, in the assessment of stroke severity in acute ischemic stroke.
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INTRODUCTION
Stroke is one important cause of mortality and morbidity as well as socioeconomic 
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bility of stroke management compared to simple usage of 
IV-tPA. 
Herein, we investigated the usefulness of KPSS in as-
sessing the severity of stroke compared to the NIHSS in pa-
tients who may be candidates for thrombolysis who arrived 
to a hospital within 6 hours of symptom onset. 
MATERIALS AND METHODS
　　　
We retrospectively analyzed a prospective registry database 
of all consecutive patients included in the Brain Salvage 
through Emergency Stroke Therapy (BEST) program con-
ducted at a 2000-bed tertiary academic hospital with an an-
nual ED census of 65000. The institutional review board of 
Yonsei University Health System reviewed and approved 
the study. The study included patients with ischemic stroke 
or TIA on ED arrival within 6 hours of symptom onset be-
tween Sep 1, 2010 and Sep 30, 2011. 
In our hospital, the BEST program, based on the comput-
erized physician order entry (CPOE) system, was used to 
effectively guide the operation of a pre-existing stroke team 
since 2004. The CPOE system was used for program acti-
vation/deactivation, communication/consultation processes, 
entering predetermined standing order sets, providing spe-
cific protocols/guidelines, and assessment of the program 
efficacy.7,10
Upon arrival of a patient to the ED, physicians, nurses, or 
emergency medical technicians in the triage area identified 
candidates for the BEST program as soon as possible ac-
cording to predetermined guidelines. The guidelines includ-
ed the five stroke warning signs (sudden numbness or weak-
ness of the face, arms, or legs; sudden confusion, trouble 
speaking or understanding speech; sudden trouble seeing in 
one or both eyes; sudden severe headache with no known 
cause; sudden trouble walking, dizziness, loss of balance, 
or loss of coordination) prepared by the American Heart 
Association (AHA) stroke council for the general popula-
tion.4,7,10 When a patient had at least one warning sign and 
arrived within 12 hours after symptom onset, an ED physi-
cian in the triage area activated the BEST program by se-
lecting the activation icon at the order entry window. Once 
the program was activated, the patient’s name in the patient 
list was highlighted orange; in this way, every team member 
could easily and immediately recognize BEST patients.7,10 
At the same time, an ED physician immediately consulted 
with an on-call neurologist and senior ED physicians. To 
burdens.1 The ultimate goal of stroke care is to minimize 
acute brain injury and maximize patient recovery.2 A com-
mon concept is that “time is brain” due to the time-sensitive 
nature of brain tissue injury.3 A community-oriented “stroke 
chain of survival,” much like the adult chain of survival for 
sudden cardiac arrest, includes rapid recognition of stroke 
warning signs and activation of the emergency response 
system: rapid emergency medical system (EMS) dispatch, 
transport, and prehospital notification; triage to a stroke 
center; and finally, rapid diagnosis, treatment, and disposi-
tion in the hospital.2 
EMS providers can identify stroke patients with prehos-
pital stroke screen tools in 30-60 seconds using the Cincin-
nati Prehospital Stroke Scale (CPSS) or the Los Angeles 
Prehospital Stroke Screen (LAPSS).4-6 However, LAPSS 
and CPSS have only been used to discriminate between 
acute stroke and urgent neurologic disorders.5,6 
In stroke treatment, intravenous administration of tissue 
plasminogen activator (IV-tPA) can improve outcomes for 
a broad spectrum of patients able to be treated within 3 
hours of symptom onset.4 In addition to IV-tPA for brain 
salvage, intra-arterial thrombolysis can benefit select pa-
tients who have had a major stroke within 6 hours of symp-
tom onset, but who are not candidates for IV-tPA.7 EMS 
personnel should consider triage to a stroke center for great-
er stroke management, and a rapid triage system for assess-
ing stroke severity should be used in the emergency depart-
ment (ED) to minimize diagnostic and therapeutic delay.2 
The National Institutes of Health Stroke Scale (NIHSS) 
provides important information about the severity of a stroke 
and informs early prognosis and decisions about acute treat-
ment.4 However, this stroke-scoring scale is relatively time-
consuming and unnecessarily sophisticated for field use.8 Al-
though CPSS and LAPSS can help rapidly recognize the 
symptoms of acute stroke, important information about the 
severity of stroke cannot be determined by these stroke 
scales.3 
The Kurashiki Prehospital Stroke Scale (KPSS) was de-
veloped to assist in deciding whether to transfer a patient to 
an appropriate EMS stroke facility in Japan.9 Kimura, et al.9 
revealed concordance in stroke severity between the KPSS 
and NIHSS in assessing acute stroke and transient ischemic 
attack (TIA) for patients admitted within 3 hours of symp-
tom onset. Additionally, early administration of intra-arteri-
al thrombolysis should be considered as a possible measure 
to improve clinical outcomes both in the field and the ED.4 
However, intra-arterial thrombolysis requires a higher capa-
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We compared baseline characteristics by Mann-Whitney 
test and chi-square test. The independent predictors of out-
comes were determined using multivariate logistic regres-
sion analysis. For this analysis, variables of p<0.05 on the 
univariate analysis were entered. All values of p<0.05 were 
considered significant. Statistical analysis was conducted us-




A total of 737 consecutive patients were admitted to our ED 
and included in the BEST program. A total of 191 patients 
with symptom onset of greater than 6 hours previous were 
excluded. A total of 254 patients diagnosed with either 
hemorrhagic stroke (n=93), brain tumors (n=3) or with an-
other medical disease (n=155) were also excluded. 
A total of 295 (40.0%) consecutive patients diagnosed 
with ischemic stroke or TIA and who presented within 6 
hours after symptom onset were included in this study. Of 
these, 11 were excluded due to incomplete data such as in-
complete stroke scoring, lack of evaluation for stroke due 
to combined life-threatening diseases, or transfer from an-
other hospital after magnetic resonance or IV-tPA. One 
hundred eighty-four of the remaining 284 patients (64.8%) 
were admitted within 3 hours. In this study, IV-tPA was ad-
ministered to 41 patients (22.3%), IA-UK was administered 
to five patients (2.7%), and sequential combination t-PA 
and IA-UK was administered to 11 patients (6.0%) (Fig. 1).
 Fig. 2 shows a scatter diagram of KPSS scores determined 
by EMT and NIHSS scores by neurologists for patients with 
onset within 6 hours (Fig. 2A) and 3 hours (Fig. 2B) before 
admission. Excellent correlation was demonstrated between 
KPSS and NIHSS scores within 6 hours [R=0.869; 95% 
confidence interval (CI, 0.837-0.895), p<0.0001] and 3 hours 
[R=0.879; 95% CI (0.840-0.907), p<0.0001] before admis-
sion (Fig. 2).
Table 1, an ROC curve, which measured the effective-
ness of KPSS as a diagnostic scoring tool for stroke severi-
ty by comparing KPSS and NIHSS, indicated an optimal 
threshold value at the cut-off score of 3 on the KPSS in pa-
tients within 3 hours and 6 hours. For actual usage of IV-
tPA and IA-UK, the cut-off value of 3 provided 98.1% sen-
sitivity and 70.7% specificity for administration of IV-tPA 
within 3 hours and 95.5% sensitivity and 74.3% specificity 
for administration of IV-tPA or IA-UK within 6 hours. There 
were significant differences in KPSS cutoffs <3 and ≥3 for 
effectively inform computed tomography (CT) and blood 
test technicians, medical orders for a CT scan and blood 
testing automatically activated an alarm, a beeping sound, 
and a pop-up window on the technician’s monitor.7,10 Thus, at 
the same time medical orders were submitted, technicians 
were alerted and could prepare for the arrival of the patient or 
blood samples, enabling immediate and rapid examinations. 
The BEST program was deactivated either after IV-tPA ad-
ministration to the patient or once it was determined that 
thrombolytic treatment would not be indicated.7,10 
When a patient suspected of suffering a stroke arrived in 
the ED, the BEST program was activated according to a 
predetermined protocol. Once admitted to the ED, the KPSS 
was assessed by one of six emergency medical technicians 
(EMTs) included in the study, while the NIHSS score was 
determined by a neurologist in the ED. Patients were ex-
cluded from the study if symptom onset occurred more than 
6 hours before admission, if a hemorrhagic stroke or a brain 
tumor was revealed in non-contrast CT, or if another medi-
cal disease such as encephalitis, seizure, hypoglycemia, or 
syncope was diagnosed after admission. To achieve a pre-
cise diagnosis, we performed diffusion-weighted magnetic 
resonance imaging and angiography or brain CT angiogra-
phy after non-contrast CT. According to previously pub-
lished criteria, IV-tPA was administered to patients diag-
nosed with acute stroke of less than 3 hours duration, and 
intra-arterial thrombolysis was performed in selected pa-
tients with a major stroke of less than 6 hours duration oc-
curring by middle cerebral artery, vertebral, or basilar artery 
occlusion and who were not otherwise candidates for IV-
tPA or for whom there was no improvement after adminis-
tration of IV-tPA.2,4 
Statistics
Demographic and clinical data are presented as medians (q1, 
q3) or a proportion, as appropriate. Correlation between 
KPSS and NIHSS scores was analyzed using Spearman’s 
rank correlation. Patients with a NIHSS score of 5-22 were 
considered candidates for IV-tPA if symptom onset was less 
than 3 hours before admission. A NIHSS score >5 qualified 
patients for intra-arterial urokinase (IA-UK) treatment if 
symptom onset had occurred less than 6 hours previous. 
A cut-off KPSS was estimated using Youden’s method 
among candidates for IV-tPA and IA-UK by comparing 
KPSS and NIHSS. Youden’s method was used to find an 
optimal cutoff point in an receiver operating characteristic 
(ROC) curve to maximize sensitivity and specificity.
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scores ranging from 0 to 13. The maximum of 13 points 
represented the most severe symptoms (Fig. 3). Kimura, et 
al.9 revealed that the KPSS can be used to identify stroke 
patients and to evaluate stroke severity. Additionally, Igu-
chi, et al.3 also demonstrated that KPSS is in reliable con-
cordance with NIHSS for patients within 3 hours of stroke 
onset, but that patients with a KPSS ≥4 had a relatively 
greater chance of receiving IV-tPA. IV-tPA is currently the 
only FDA-approved medical therapy for patients with acute 
ischemic stroke.4 Nevertheless, several recent studies have 
demonstrated that intra-arterial thrombolysis may be bene-
ficial in the treatment of carefully selected patients with 
middle cerebral, vertebral, or basilar artery occlusion or oc-
clusion of the anterior circulation.4,11
actual usage of IV-tPA (p<0.0001) or IA-UK (p<0.0001) 
(Table 2). Significant associations for KPSS scores ≥3 were 
revealed in actual IV-tPA usage [odds ratio (OR) 125.598; 
95% CI 16.443-959.368, p<0.0001] and actual IV-tPA or IA-
UK usage (OR 58.733; 95% CI 17.272-199.721, p<0.0001) 
(Table 3).
DISCUSSION
The KPSS was developed in 2008 to assess the severity of 
a stroke. This scoring system was constructed using four 
metrics including level of consciousness, disturbance of 
consciousness, motor weakness, and language, with total 
Fig. 1. Enrollment and clinical outcomes. BEST, Brain Salvage through Emergency Stroke Therapy; IV-tPA, intravenous administration of tissue plasmino-
gen activator; IA-UK, intra-arterial urokinase; MR, magnetic resonance; AMI, acute myocardial infarction.
Fig. 2. An excellent correlation was demonstrated between KPSS and NIHSS within 6 hours (A) [R=0.869; 95% CI (0.837-0.895), p<0.0001] and 3 hours (B) 
[R=0.879; 95% CI (0.840-0.907), p<0.0001] before admission. KPSS, Kurashiki Prehospital Stroke Scale; NIHSS, National Institutes of Health Stroke Scale.
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Table 1. A Cut-Off KPSS Value Was Estimated Using Youden’s Method for IV-tPA and IA-UK Candidates by Comparing be-
tween KPSS and NIHSS and by Estimating Cut-Off Values for Patients Who Actually Received IV-tPA and IA-UK in the Emer-
gency Department
Cut-off value Sensitivity Specificity AUC Youden’s
Actual IV-tPA usage by KPSS 
  within 3 hrs
3   98.1% [94.3, 100.0] 70.7% [64.8, 76.5] 0.844 [0.809, 0.879] 0.688
Actual IV-tPA or IA-UK usage 
  by KPSS within 6 hrs
3   95.5% [90.4, 100.0] 74.3% [68.5, 80.1] 0.849 [0.810-0.887] 0.698
Comparison between KPSS and 
  NIHSS (5-22) within 3 hrs
3 89.4% [83.5, 95.3] 85.6% [80.4, 90.7] 0.875 [0.836, 0.914] 0.750
Comparison between KPSS and 
  NIHSS (5-maximum) within 6 hrs
3 90.1% [84.5, 95.6] 89.0% [84.4, 93.7] 0.896 [0.859, 0.932] 0.791
KPSS, Kurashiki Prehospital Stroke Scale; NIHSS, National Institutes of Health Stroke Scale; IV-tPA, intravenous administration of tissue plasminogen 
activator; IA-UK, intra-arterial urokinase; AUC, area under curve.
Youden’s index: (sensitivity+specificity-1).
Table 2. Clinical Outcomes of Patients with Ischemic Stroke Using a KPSS Cut-Off of 3
KPSS <3 (n=165) KPSS ≥3 (n=119) p value
Demographics
    Age   66.0 [55.0, 73.0] 72.0 [63.0, 77.0] <0.0001
    Male (%)    103 (62.4)    64 (53.8) 0.1443
    Onset to door time (min) 126.0 [64.0, 226.0] 76.0 [41.0, 183.0] 0.0004
    Coronary artery disease (%)      26 (15.8)    20 (16.8) 0.8128
    Hypertension (%)    111 (67.3)    82 (68.9) 0.7708
    Diabetic mellitus (%)      38 (23.0)    33 (27.7) 0.3667
    Hypercholesterolemia (%)      23 (13.9)    10 (8.4) 0.1509
    Smoking (%)      73 (44.2)    43 (36.1) 0.1702
    Atrial fibrillation (%)      23 (13.9)    37 (31.1) 0.0005
    Old cerebrovascular disease (%)      50 (30.3)    35 (29.4) 0.8717
Clinical Outcome (%)
    Stroke type <0.0001
        Ischemic stroke    101 (61.2)  112 (94.1)
        Transient ischemic attack      64 (38.8)      7 (5.9)
    Actual usage (%)
        IV-tPA        1 (0.6)    51 (42.9) <0.0001
        IA-UK        2 (1.2)    23 (19.3) <0.0001
        IV-tPA or IA-UK        3 (1.8)    63 (52.9) <0.0001
    Median NIHSS (%)     1.0 [0.0, 2.0] 13.0 [7.0, 18.0] <0.0001
        NIHSS (5-22)      11 (6.7)    93 (78.2) <0.0001
        NIHSS (5-maximum)      11 (6.7)  100 (84.0) <0.0001
NIHSS, National Institutes of Health Stroke Scale; KPSS, Kurashiki Prehospital Stroke Scale; IV-tPA, intravenous administration of tissue plasminogen 
activator; IA-UK, intra-arterial urokinase.
[ ]: interquartile range.
Table 3. The Independent Predictors of Outcome Were Determined Using Multivariate Logistic Regression Analysis
Actual IV-tPA usage Actual IV-tPA or IA-UK usage 
OR (95% CI) p value OR (95% CI) p value
Age - - - -
Onset to Door time (min) 0.980 [0.972-0.988] <0.0001 0.990 [0.985-0.994] <0.0001
Hypercholesterolemia 0.120 [0.012-1.156]   0.0665 0.189 [0.036-0.982]   0.0476
Atrial fibrillation - - - -
KPSS ≥3   125.598 [16.443-959.368] <0.0001     58.733 [17.272-199.721] <0.0001
KPSS, Kurashiki Prehospital Stroke Scale; IV-tPA, intravenous administration of tissue plasminogen activator; IA-UK, intra-arterial urokinase; OR, odds 
ratio; CI, confidence interval.
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patients requiring crucial treatments. Compared to previous 
studies showing a 69% sensitivity and 63% specificity at a 
cut-off of 4 for the administration of IV-tPA, these results 
demonstrate that a cut-off of 3 could improve both sensitiv-
ity and specificity and can be applied to stroke patients with-
in the 6 hour symptom onset window. On scene, the KPSS 
can be used to identify candidates for IV-tPA and IA-UK, 
evidenced by its excellent correlation with the NIHSS in the 
assessment of stroke severity. Additionally, KPSS can be 
used to more rapidly initiate stroke management by faster 
triage of patients in the hospital.
Limitations
There are several limitations to our study. First, although 
the KPSS is a useful prehospital stroke scale, our KPSS as-
sessments were not determined by EMTs on scene, but 
were instead conveniently determined by EMTs in the ED. 
Second, the BEST program was only activated if at least 
one of five stroke warning signs described by the AHA was 
identified within 12 hours after symptom onset. After initial 
screening by BEST activation, the patient’s KPSS score 
could be assessed by an EMT. There might be selection 
bias. Third, although an educational program for the pre-
hospital stroke scale, including KPSS, was provided to par-
ticipants, inter-observer reliability could not be established 
Although IV-tPA was administered to acute stroke pa-
tients within 3 hours of onset, the patients whose condition 
had not improved at the end of IV-tPA infusion were subse-
quently treated with selective IA-UK. The strategy of using 
conventional-dose IV-tPA followed by IA-UK in patients 
without an early clinical response to IV treatment was 
shown to be both safe and feasible. This strategy achieved 
high rates of complete arterial recanalization and good func-
tional outcomes.12,13 Considering the benefits of treating 
acute ischemic stroke, EMS personnel should consider tri-
aging to a stroke center, which is best able to manage the 
patient, by assessing stroke severity within an appropriate 
period of time.2 The widely used CPSS and LAPSS can be 
used to rapidly recognize acute stroke, but these prehospital 
stroke scales cannot determine the severity of a stroke.3 
It is difficult to apply the NIHSS to stroke patients on the 
scene.8 However, our results showed that the KPSS strong-
ly correlates with the NIHSS in patients both within 3 hours 
and 6 hours of stroke onset. Unlike previous studies with a 
cutoff KPSS of 4, a patient with a KPSS score ≥3 can be 
considered for administration of both IV-tPA and IA-UK 
when symptom onset was within 3 and 6 hours. A cut-off 
KPSS value of 3 was also estimated for patients actually re-
ceiving IV-tPA and IA-UK. A prehospital stroke scale for 
assessing severity should be pursued as a screening tool for 
Scoring (total disorder: 13 points)
Consciousness level
Level of consciousness
    Alert Normal: 0 points
    Arousal by stimulation 1 point
    No response 2 points
Consciousness 
  disturbance
Ask for patient’s name
    Correct Normal: 0 points
    Incorrect 1 point
Motor weakness 
  (kinetic paralysis)
Ask the patient to close eyes, raise arms to the front with palms down 
  (with gestures) Right hand Left hand
    Being able to keep arms raised in parallel Normal: 0 points Normal: 0 points
    Being able to raise arms but not to keep them in position so that they go downward 1 point 1 point
    Unable to raise arms 2 points 2 points
Instruct the patient to close eyes, raise legs from the bed to the front with gestures Right leg Left leg
    Being able to keep legs raised in parallel Normal: 0 points Normal: 0 points
    Being able to raise legs but not to keep them in position so that they go downward 1 point 1 point
    Unable to raise legs 2 points 2 points
Language
Ask the patient to say ‘It’s fine today’ repeatedly
    Being able to clearly say it repeatedly Normal: 0 points
    Either unclear (slurred) or abnormal 1 point
    Keeping silent, unable to understand linguistically 2 points
Total …points
Fig. 3. Kurashiki Prehospital Stroke Scale. Adapted from Iguchi, et al. Cerebrovase Dis 2011;31:51-6 with permission from S. Karger AG. Basel.3
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3. Iguchi Y, Kimura K, Watanabe M, Shibazaki K, Aoki J. Utility of 
the Kurashiki Prehospital Stroke Scale for hyperacute stroke. 
Cerebrovasc Dis 2011;31:51-6.
4. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Fur-
lan A, et al. Guidelines for the early management of adults with 
ischemic stroke: a guideline from the American Heart Association/
American Stroke Association Stroke Council, Clinical Cardiology 
Council, Cardiovascular Radiology and Intervention Council, and 
the Atherosclerotic Peripheral Vascular Disease and Quality of 
Care Outcomes in Research Interdisciplinary Working Groups: 
the American Academy of Neurology affirms the value of this 
guideline as an educational tool for neurologists. Stroke 2007;38: 
1655-711.
5. Kothari RU, Pancioli A, Liu T, Brott T, Broderick J. Cincinnati 
Prehospital Stroke Scale: reproducibility and validity. Ann Emerg 
Med 1999;33:373-8.
6. Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL. Identi-
fying stroke in the field. Prospective validation of the Los Angeles 
prehospital stroke screen (LAPSS). Stroke 2000;31:71-6.
7. Nam HS, Han SW, Ahn SH, Lee JY, Choi HY, Park IC, et al. Im-
proved time intervals by implementation of computerized physi-
cian order entry-based stroke team approach. Cerebrovasc Dis 
2007;23:289-93. 
8. Llanes JN, Kidwell CS, Starkman S, Leary MC, Eckstein M, Sav-
er JL. The Los Angeles Motor Scale (LAMS): a new measure to 
characterize stroke severity in the field. Prehosp Emerg Care 
2004;8:46-50.
9. Kimura K, Inoue T, Iguchi Y, Shibazaki K. Kurashiki prehospital 
stroke scale. Cerebrovasc Dis 2008;25:189-91.
10. Heo JH, Kim YD, Nam HS, Hong KS, Ahn SH, Cho HJ, et al. A 
computerized in-hospital alert system for thrombolysis in acute 
stroke. Stroke 2010;41:1978-83. 
11. Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S, 
et al. Randomized trial of intraarterial infusion of urokinase within 
6 hours of middle cerebral artery stroke: the middle cerebral artery 
embolism local fibrinolytic intervention trial (MELT) Japan. 
Stroke 2007;38:2633-9. 
12. Lee KY, Kim DI, Kim SH, Lee SI, Chung HW, Shim YW, et al. 
Sequential combination of intravenous recombinant tissue plas-
minogen activator and intra-arterial urokinase in acute ischemic 
stroke. AJNR Am J Neuroradiol 2004;25:1470-5.
13. IMS Study Investigators. Combined intravenous and intra-arterial 
recanalization for acute ischemic stroke: the Interventional Man-
agement of Stroke Study. Stroke 2004;35:904-11.
for KPSS among EMTs or for NIHSS among neurologists 
in our study. There is also a discrepancy in the timing of the 
KPSS and NIHSS assessments. Any difference in symp-
toms could not be accounted for in our study. Fourth, new 
evidence for IA-UK in patients with vertebral or basilar ar-
tery occlusion within 24 hours of symptoms onset suggests 
that intra-arterial thrombolysis may be used.3 Our study 
was limited to patients presenting within 6 hours of symp-
tom onset. In the future, a larger prospective study with 
KPSS assessment performed by EMTs on the scene within 
24 hours of symptom onset will be needed to investigate 
the effectiveness of this stroke triaging tool.
In conclusion, the KPSS is an effective prehospital stroke 
scale for the assessment of stroke severity that can be used 
to identify candidates for IV-tPA and IA-UK as evidenced 
by excellent correlation with the NIHSS in patients with 
acute ischemic stroke.
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